Episiotomy. Disruption of perineal obstetric wound
Conditions
Interventions
Intervention 1: Intervention group: Receiving cinnamon ointment. Intervention 2: Control group: Receiving placebo ointment.
Treatment - Drugs
Placebo
Intervention group: Receiving cinnamon ointment
Control group: Receiving placebo ointment
Sponsors
Research deputy of Tabriz university of medical sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: • being primipara • being literate • Access to telephone line • gestational age 37 to 42 weeks • Having a singleton live child • aged 20 to 35 years • Repair of Episiotomy incision by a provider with at least six months experience• willingness to participate in the study. • willingness and ability to continue coming to Alzahra or Taleghani hospital for the care Exclusion criteria: • use of drugs or psychotropic substances (according to the woman or her physical records) • use of certain drugs (according to the participant) • history of diseases like systemic disease, cardiac, renal, pulmonary, coagulation disorders, immune deficiency, connective tissue disorders, diabetes, mental illness, haemophilia that may intervene with the healing • following a special diet • long-term rupture of amniotic sac (over 18 hours) • severe anaemia (haemoglobin less than 7) (based on haemoglobin assessed at admission) • history of hypersensitivity to certain drugs • extension of episiotomy (tears of grade 3 or 4) • operative delivery
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of episiotomy pain. Timepoint: Befor intervention and 4±1 , 8±1 hours after intervention and ten days after intervention. Method of measurement: Visual analogue scale (VAS).;Episiotomy healing wound. Timepoint: Pre intervention and 8±1 hour after intervention and ten days afer delivery. Method of measurement: REEDA (Redness, Edema, Ecchymosis, Discharge, Approximation. | — |
Secondary
| Measure | Time frame |
|---|---|
| ?Number of Mefenamic acid capsules used. Timepoint: Tenth day after delivery. Method of measurement: count of remaining Capsules. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammadi Azam
Faculty of Nursing and Midwifery, Tabriz University of Medical Sciences
Outcome results
None listed